- Austria (Website)
- Czech Republic (Website)
- Denmark (Website)
- Finland (Website)
- France (Website)
- Germany (Website)
- Italy (Website)
- Ivory Coast
New immunoanalyzer with full traceability and automation
VIDAS® 3 is a benchtop immunoassay system designed specifically for low throughput testing. Fully automated, it is based on the proven and robust ELFA technology for high quality on-demand test results.
- Full traceability
- Specialty menu available in single-test ready-to-use format
- Bidirectional connectivity to internal and external networks
VIDAS® 3 is the new-generation VIDAS analyzer, a brand trusted around the world in immunoassay testing for over two decades. Designed with your lab’s specific needs and workflow in mind, it is equipped with increased automation, traceability and security for greater productivity. VIDAS 3 helps you provide precise and accountable test results for the benefit of clinicians and their patients.
- Reduced hands on time from the sample to the result
- Fully automated pipetor action with single-use, disposable tips to avoid contamination
- Automated calibration and on-board dilution
- Scanning of sample and reagent barcodes upon test loading for complete traceability of all test components
- Integrated quality control management
- Facilitated lab workflow with a simple answer to complex needs
- Calibration every 14 or 28 days, depending on the parameter
- Bi-directional LIS connectivity
- Minimal maintenance allowing operators to concentrate on higher-level tasks
- Remote access via screen-sharing
- Immediate start, no waiting
- Temperature-controlled loading bay
- 3 separate racks each containing 3 configurable segments can hold a total of 27 samples, diluents and calibrators
- 4 independent compartments can each run 3 tests
- Up to 36 tests per hour
- Specific management of emergency tests
- Intuitive touch screen interface
- Streamlined test loading, ensuring standardization within your lab
- Minimal training necessary before starting routine operations
Broad test menu
- Specialty menu in single-test format for the diagnosis of hemostasis, infectious diseases, and pregnancy
- On-demand testing: 1 patient, 1 test, 1 result
- Ready-to-use reagents
- All components needed for the test included in the kit: only 1 order reference per test
- Rapid results: from 17 to 90 minutes
|Weight||143 lbs (65 kg)|
|Electrical consumption||1.2 - 3 A|
|Power||280 VA maximum|
|Heat emission||approximately 921 BTU/hr|
|Maximum altitude||2,500 m|
|Humidity||Relative humidity : 20 to 80% (RH non-condensing)|
|Noise||Standby mode: 55dB (A)
During Analysis : 64.5 dB(A)
- 3 configurable racks to load up to 27 patient samples, controls, calibrators and diluents
- Disposables rack for tips and dilution cups
- 4 sections to allow continual access
Please contact your local bioMérieux representative for more information.
VIDAS® 3: Healthcare Reagents - Clinical Laboratories
VIDAS® 3 Test Menu
VIDAS® B·R·A·H·M·S® PCT
What if you had an extra piece of information to manage bacterial infections?
In its early phase, bacterial infections and sepsis can be difficult to distinguish from non-bacterial infectious and/or inflammatory conditions. Moreover, assessing the progression of bacterial infection is sometimes a challenge. As a consequence, it may be difficult to make the appropriate clinical decision for individual patients.
PROCALCITONIN: the “extra piece” which can make the difference Procalcitonin (PCT) is often increased during systemic bacterial infection and sepsis. This biomarker is now being recognized as a useful tool in the diagnostic process.
VIDAS® B·R·A·H·M·S® PCT is an innovative procalcitonin assay. This assay is performed on the VIDAS® system, which is fully adapted for emergency or stat conditions where rapid turnaround time is important.
Diagnosis of bacterial infections and sepsis; rapid procalcitonin assay used with critically ill patients to assess risk for progression to severe sepsis and septic shock
What is Sepsis?
Definitions for the terms “SIRS”, “sepsis”, “severe sepsis” or “septic shock” have been proposed by the ACCP/SCCM consensus conference in 1992, and are now widely used (see table below 1).1
Clinical need for earlier detection of sepsis
Early detection and specific clinical intervention has been shown to be crucial for the improved outcome of patients with sepsis. However, sepsis can be difficult to distinguish from other, non-infections conditions in critically ill patients with clinical signs of acute inflammation and negative microbiological results. Therefore, in the early phase of the disease process it may be difficult to decide on the appropriate therapeutic measures for the individual patient.
Additional specific information may be helpful to increase the accuracy of sepsis diagnosis at an early stage. A parameter which fulfills these demands to a high degree is procalcitonin.
Fast and highly specific PCT increase in bacterial infection and sepsis One major advantage of PCT compared to other parameters is its early and highly specific increase in response to severe systemic bacterial infections and sepsis.2,3 Therefore, in septic conditions, increased PCT levels can be observed 3-6 hours after an infectious challenge.
PCT levels are usually low in viral infections, chronic inflammatory disorders or autoimmune processes. PCT levels in sepsis are generally greater than 0.5-2 ng/mL and often reach values between 10 and 100 ng/mL, or considerably higher in individual cases, thereby enabling diagnostic differentiation between these various clinical conditions and a severe bacterial infection (sepsis) (Figure 1).
1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992; 101: 1644-55.
2. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, Vadas L, Pugin J; Geneva Sepsis Network. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med. 2001; 164: 396-402.
3. Muller B, Becker KL, Schachinger H, Rickenbacher PR, Huber PR, Zimmerli W, Ritz R. Crit Care Med. 2000; 28: 977-83. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit.
What is PCT?
PCT is the prohormone of calcitonin (CT). Whereas CT is secreted by the C-cells of the thyroid after hormonal stimulation, PCT can be produced by numerous cell types and organs after proinflammatory stimulation, especially when caused by bacterial challenge.1
In healthy people, plasma PCT concentrations are found to be below 0.05 ng/ml, but can increase up to 1,000 ng/ml in patients with severe sepsis or septic shock.
Elevated PCT levels indicate bacterial infection accompanies by a systemic inflammatory reaction. Localized infections do not generally cause circulating PCT increases. Slightly elevated PCT concentrations are observed in bacterial infections with minor systemic inflammatory response.
Very high values have been observed during acute disease conditions with severe systemic reactions to infection, in cases of severe sepsis or septic shock.
1. Christ-Crain M, Müller B. Procalcitonin in bacterial infections – hype, hope or more or less? Swiss Med Wkly 2005; 135: 451-60.
Visit Sepsis Know From Day One and listen to our podcast series, an educational series that provides a forum for scientific exchange and the sharing of experiences to help in the understanding and management of patients suspected of having sepsis.
VIDAS® D-Dimer Exclusion™
- The most referenced test for the exclusion of Venous Thromboembolism (VTE)
- A proven ELISA technique
- Expert validation in extensive prospective management clinical studies
- First FDA cleared assay for exclusion of Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) for outpatients with signs and symptoms of DVT and PE
- Rapid turn around time to support emergency medicine needs
- Upcoming webinar: D-Dimer Testing: New CLSI Guidelines and Implications for Your Lab
Just One Test. A Clear Answer. The Right Choice.
About Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE)
Watch the video:
Especially during summer months, when patients are most vulnerable and concerned about Lyme Disease:
- Is your laboratory providing quick answers?
- Are you wasting too much time with multi-step laborious procedures?
- Are you just waiting for results from your reference labs?
VIDAS® Lyme IgG/IgM can help you provide quick answers and improve your work flow and turn-around time.
VIDAS® Lyme IgG/IgM 30298-011
- Results in 35 minutes
- Automated assay
- All reagents, calibrators, and controls are provided in the assay kit
- Most reported assay in Lyme CAP survey (TTD-B 2010)
Disclaimer: All VIDAS instruments and assays are to be run by laboratory personnel in a laboratory certified under CLIA or by a CLIA approved State laboratory program. All personnel tasked with operating the VIDAS systems should be qualified and undergo a yearly competency assessment as defined in 42 CFR 493 subpart M “Personnel for Nonwaived Tests."
VIDAS® 3 Instrument Services
- An extensive network of skilled Systems Engineers and Application Specialists for on-site instrument maintenance
- Remote support services via screen-sharing for immediate solutions
Certification support and integrated Quality Control
- VIDAS® validation package for your instrument and methodology
- Support in obtaining ISO 15189 certification
- On-site and off-site training sessions
- E-learning courses
- A wide offer to continually develop your lab’s skills and expertise
To have access to more resources and strengthen your expertise, register now on www.biomerieux.com/techlib